Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMissing a single week of Mounjaro is not a crisis. The Mounjaro SmPC states that if you miss a dose, you can take it within four days; after that, skip it and resume your usual schedule the following week. Your next injection then falls on the original day. Tirzepatide, the active medicine, has a half-life of roughly five days, so one missed week does not instantly undo progress — but the science is clear that consistency matters. These are prescription-only medicines, and any decision to delay or restructure your schedule should involve your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The clinical rationale for once-weekly dosing is built around tirzepatide's pharmacokinetic profile. With a half-life of roughly five days, a single missed injection means blood levels fall to somewhere between 50–70% of steady-state by the end of week two, not zero. That is meaningfully different from medicines that clear the body within hours. The practical consequence: you are unlikely to feel an abrupt return of hunger in the first few days after a missed pen, but appetite suppression does gradually ease as the week progresses.
A misconception worth clearing up: some people assume that because they are injecting once a week, missing one dose is equivalent to pausing treatment for a fortnight. Pharmacologically, that is not quite right. The slow washout means the transition is gentler than it feels, though it is still real. The Mounjaro overview page explains how the dual GIP and GLP-1 mechanism produces this extended action.
The SURMOUNT-1 trial, which enrolled 2,539 adults and ran for 72 weeks, demonstrated average weight reduction of around 20–21% at the 15mg dose. That result came from consistent weekly dosing under controlled conditions. Real-world adherence studies consistently show that gaps in dosing blunt the trajectory, not through any single missed pen, but through the cumulative effect of irregular schedules over months. The NHS tirzepatide medicines page notes the importance of taking doses as close to schedule as possible.
The Mounjaro Summary of Product Characteristics is the legal, authoritative source for missed-dose guidance. Its instruction is precise: if you have missed your usual injection day, take it as soon as you remember, provided you are still within four days of the missed dose. If more than four days have passed, leave it out entirely. Do not double up. Your next dose goes in on the day you would normally inject, keeping the weekly interval intact.
That four-day window is worth knowing because it removes quite a lot of anxiety. A Monday dose missed and remembered on Thursday is still retrievable. A Monday dose missed and only noticed the following Sunday is not, you simply restart on the next Monday. If you are unsure where you stand, the Patient Information Leaflet inside every Mounjaro pen box has this written out step by step. Detailed questions about your personal schedule are best handled by your prescriber; our frequently asked questions covers a range of practical queries if you want a quick orientation first.
One thing to plan for after any gap: the gastrointestinal side effects that most people experience in the early weeks of treatment (nausea, loose stools, indigestion) can return more strongly when a dose is resumed after several days without. This is because the steady-state damping of gastric motility has partly unwound. It does not mean something has gone wrong, it mirrors what happens when the schedule is first started.
A single missed week sits in very different territory from two consecutive missed doses. Missing two weeks of Mounjaro raises additional questions about whether to restart at a lower dose to minimise side effects, a decision that requires clinical input. The further out you get, the less the pharmacokinetic buffer protects you, and the more the reintroduction resembles a fresh start.
There are also practical situations (planned surgery, illness, a holiday where the pen cannot be kept refrigerated throughout) where an intentional break might be discussed with a prescriber in advance rather than handled reactively. If you are taking an oral contraceptive pill alongside tirzepatide, it is worth knowing that absorption of the pill may be reduced during the first four weeks of treatment and for four weeks after each dose increase, so contraceptive cover should be discussed with your GP. NHS England's guidance on weight-management injections covers contraception and surgical planning considerations in more detail.
If you are mid-titration and a gap has meant returning to an earlier dose strength, the cost picture can shift. Our weight-loss treatments page sets out how private treatment is structured, which is useful context if your schedule has changed and you want to understand your options. The broader question of what different gaps mean in practice (including returning after illness) is covered in detail on the missing a week of Mounjaro guide.
Most single missed doses need nothing more than applying the four-day rule. A prescriber's input becomes more important in a few specific situations: a gap of more than two weeks, significant weight regain after an unplanned break, a change in the medical conditions for which treatment was prescribed, or any new symptoms that emerged during the gap. Severe, persistent stomach pain that radiates to the back (with or without vomiting) warrants urgent medical attention regardless of where you are in your dosing cycle; the MHRA highlighted acute pancreatitis as a known, if infrequent, risk for GLP-1 medicines in early 2026.
Our prescribers review every repeat order before it is dispensed. That means if your schedule has been disrupted and you have questions about how to resume, the consultation process is the natural place to raise them. You are not left to piece it together from a leaflet alone. If you are considering restarting after a longer break, the what happens if you miss a week of Mounjaro page addresses the reintroduction question directly, and whether it is medically acceptable to miss a week covers the clinical framing more broadly.
If something about your treatment feels off after resuming, do not wait for the next scheduled check-in. Reach out through our aftercare support, clinical help is available seven days a week.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.